Matthew P. Ottmer
2016
In 2016, Matthew P. Ottmer earned a total compensation of $1.4M as Chief Operating Officer at Momenta Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $252,281 |
|---|---|
| Salary | $450,000 |
| Stock Awards | $733,500 |
| Other | $13,091 |
| Total | $1,448,872 |
Ottmer received $733.5K in stock awards, accounting for 51% of the total pay in 2016.
Ottmer also received $252.3K in non-equity incentive plan, $450K in salary and $13.1K in other compensation.
Rankings
In 2016, Matthew P. Ottmer's compensation ranked 6,422nd out of 14,075 executives tracked by ExecPay. In other words, Ottmer earned more than 54.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,422 out of 14,075 | 54th |
Division Manufacturing | 2,371 out of 5,489 | 57th |
Major group Chemicals And Allied Products | 776 out of 1,895 | 59th |
Industry group Drugs | 592 out of 1,538 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 108 out of 279 | 61st |
Source: SEC filing on April 27, 2017.
Ottmer's colleagues
We found five more compensation records of executives who worked with Matthew P. Ottmer at Momenta Pharmaceuticals in 2016.
2016
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2016
Scott Storer
Momenta Pharmaceuticals
Chief Financial Officer
2016
Ganesh Kaundinya
Momenta Pharmaceuticals
Chief Scientific Officer
2016
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2016
Richard Shea
Momenta Pharmaceuticals